Popular Articles

Rwanda Launches Campaign To Address Cross-Generational Sex
The Rwanda Ministry of Youth recently launched a six-month campaign aimed at reducing the trend of cross-generational sex, which some health officials say is contributing to the spread of HIV among young people in the country, the New Times/AllAfrica.com reports. Rwanda"s National Commission for the Fight Against AIDS, USAID and Population Services International launched the campaign urging youth to avoid having sex with older people. The minister of youth, Protais Mitali, said that all institutions in the country should help address the trend in order to curb the spread of HIV among young people. According to Anita Asiimwe, executive secretary of the commission, data show that Rwandan women ages 20 to 24 are five times more likely to be HIV-positive than men their age. She added that statistics indicate that one out of every 10 girls had her first sexual experience with a man 10 or more years older. She added, "Since older men are much more likely to be [HIV-positive] than their male counterparts, young girls appear to be getting infected by older men, rather than by boys of their age." Staci Leuschuer with PSI Rwanda said that there are lower rates of condom use among young people, noting that about 40% of young people report condom use and that about 24% to 25% of girls ages 15 to 24 are using condoms (Mutara, New Times/AllAfrica.com, 5/24).
generic viagra online
Small Businesses, Doctors Voice Concerns About Health Reform
"Small business is suddenly playing a big role in negotiations over health care," NPR reports. "Supporters and opponents of various plans to overhaul the system are all trying to paint themselves as champions of mom and pop entrepreneurs." The National Federation of Independent Business is "not happy with the health care bill taking shape in the House this week - especially its requirement for all but the smallest employers to provide health insurance or pay a penalty." Meanwhile, "the Democratic National Committee quickly lined up its own panel of small business owners to defend the House plan."
News of the day
Biolex Therapeutics Announces Completion Of Enrollment In SELECT-2 Phase 2b Trial Of Locteron(R) In Chronic Hepatitis C
Biolex Therapeutics, Inc. announced that it has completed patient enrollment in the SELECT-2 Phase 2b trial of its lead product candidate Locteron® for the treatment of chronic hepatitis C. Locteron, controlled-release interferon alpha 2b, is designed to improve patient care by providing a more convenient once-every-two week dosing schedule and by reducing the side effects, including flu-like symptoms, associated with pegylated interferons, the current standard of care.
Nutrition

Red Wine Ingredient Demonstrates Significant Health Benefits: Research Review

The benefits of alcohol are all about moderation. Low to moderate drinking - especially of red wine - appears to reduce causes of mortality, while too much drinking causes multiple organ damage. A mini-review of recent findings on red wine"s polyphenols, particularly one called resveratrol, will be published in the September issue of Alcoholism: Clinical & Experimental Research. The review is also available at Early View. "Reports on the benefits of red wine are almost two centuries old," said Associate Professor Lindsay Brown, of the School of Biomedical Sciences at The University of Queensland and corresponding author for the study. "The media developed the more recent story of the French paradox in the early 1990s. "However, studies on the actions of resveratrol, one of the active non-alcoholic ingredients, were uncommon until research around 1997 showed prevention of cancers. This led to a dramatic interest in this compound." Red wine contains a complex mixture of bioactive compounds, including flavonols, monomeric and polymeric flavan-3-ols, highly colored anthocyanins, as well as phenolic acids and the stilbene polyphenol, resveratrol. Brown said that some of these compounds, particularly resveratrol, appear to have health benefits. "The breadth of benefits is remarkable - cancer prevention, protection of the heart and brain from damage, reducing age-related diseases such as inflammation, reversing diabetes and obesity, and many more," Dr Brown said. "It has long been a question as to how such a simple compound could have these effects but now the puzzle is becoming clearer with the discovery of the pathways, especially the sirtuins, a family of enzymes that regulate the production of cellular components by the nucleus. "Is resveratrol the only compound with these properties? This would seem unlikely, with similar effects reported for other components of wine and for other natural products such as curcumin. However, we know much more about resveratrol relative to these other compounds." UQ Professor pharmacology Stephen Taylor, said that resveratrol was the "compound du jour." "I think that red wine has both some mystique and some historical symbolism in the west," Professor Taylor said. "And of course, there are some various pleasures attached to its ingestion, all of which give it a psychological advantage edge, food-wise. Not many of us can or will eat a couple of cups of blueberries a day for years on end, but if we could do a population study for a decade or so on such a group, you might actually see similar results." Key points of the review include: - Resveratrol exhibits therapeutic potential for cancer chemoprevention as well as cardioprotection. "It sounds contradictory that a single compound can benefit the heart by preventing damage to cells, yet prevent cancer by causing cell death, Dr Brown said. "The most likely explanation for this, still to be rigorously proved in many organs, is that low concentrations activate survival mechanisms of cells while high concentrations turn on the in-built death signals in these cells."" - Resveratrol may aid in the prevention of age-related disorders, such as neurodegenerative diseases, inflammation, diabetes, and cardiovascular disease. "The simplest explanation is that resveratrol turns on the cell"s own survival pathways, preventing damage to individual cells," Dr Brown said. "Further mechanisms help, including removing very reactive oxidants in the body and improving blood supply to cells." - Low doses of resveratrol improve cell survival as a mechanism of cardio- and neuro-protection, while high doses increase cell death. "The key difference is probably the result of activation of the sirtuins in the nucleus," Dr Brown said. "Low activation reverses age-associated changes, while high activation increases the process of apoptosis or programmed cell dUQ eath to remove cellular debris. Similar changes are seen with low-dose versus high-dose resveratrol: low-dose resveratrol produces cellular protection and reduces damage, while high-dose resveratrol prevents cancers." In summary, Dr Brown said, current scientific research was starting to explain reports from the last 200 years that drinking red wine improves health. "It is a clichç© that "nature is a treasure trove of compounds," but studies with resveratrol show that this is correct. " We need to understand better the vast array of compounds that exist in nature, and determine their potential benefits to health. "There is one particular point that deserves fleshing out. "Resveratrol is largely inactivated by the gut or liver before it reaches the blood stream, where it exerts its effects - whatever they may be - good, bad, or indifferent. "Thus, most of the reseveratrol in imbibed red wine does not reach the circulation. Interestingly, absorption via the mucous membanes in the mouth can result in up to around 100 times the blood levels, if done slowly rather than simply gulping it down. Of course, we don"t know if these things matter yet, but issues like this are real and generally ignored by all." Background: Alcoholism: Clinical & Experimental Research (ACER) is the official journal of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism. Co-authors of the ACER paper, "The Biological Responses to Resveratrol and Other Polyphenols from Alcoholic Beverages," were: Lindsay Brown and Vincent Chan of the School of Biomedical Sciences at The University of Queensland, Brisbane, Australia; Paul A. Kroon of the Institute of Food Research, Norwich, UK; Dipak K. Das and Samarjit Das of the Cardiovascular Research Center at the University of Connecticut School of Medicine; Arpad Tosaki of the Department of Pharmacology at the University of Debrecen, Hungary; and Peter Feick of the Department of Medicine II at the University Hospital of Heidelberg at Mannheim, Germany. The study was funded by the National Institutes of Health, and the Dietmar Hopp Foundation. This release is supported by the Addiction Technology Transfer Center Network at http://www.ATTCnetwork.org. University of Queensland, Australia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):